干扰素联合胸腺肽治疗慢性乙型病毒性肝炎  

The efficacy of interferon and thymic peptide for treatment of chronic hepatitisB

作　　者：关琦[1] 

机构地区：[1]郑州市第六人民医院

出　　处：《中国中医药现代远程教育》2008年第10期1253-1253,共1页Chinese Medicine Modern Distance Education of China

摘　　要：目的观察重组基因干扰素α-1b与胸腺肽治疗慢性乙型病毒性肝炎(CHB)的临床疗效。方法选择门诊及住院的慢性乙型病毒性肝炎患者140例,其中干扰素治疗组90例;保肝治疗组60例。观察2组患者的肝功能。结果干扰素联合胸腺肽治疗组的ALT复常率和HBeAg阴转率均明显高于保肝治疗组,差异均有统计学意义(P<0.01)。结论干扰素α-1b与胸腺肽是目前治疗慢性乙型病毒性肝炎较为有效的药物。Objective To observe the clinical inpact factors and safety of recombinanthuman in terferon a-1b and thymic peptide for treatmemt of chronic hepatitisB(CHB) cases. Methods 150 CHB cases selected from out and in patients were divivded into 2 groups : 90 Cases in a-1b and thymic peptide teratnent group, and 60 cases in liver protectivegroup. ALT level and number of copies of HBV-DNA was detected. Results In a-1b and thymic peptide treatment group, theHBeAg negative rate, HbeAg senum inversion rate and HBV-DNA...

关 键 词：干扰素 胸腺肽 慢性乙型病毒性肝炎 

分 类 号：R512.62[医药卫生—内科学]